Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus. [electronic resource]
Producer: 20150130Description: 471-81 p. digitalISSN:- 1876-7605
- Aged
- Cardiovascular Agents -- administration & dosage
- Chi-Square Distribution
- Coronary Angiography
- Coronary Artery Disease -- diagnosis
- Diabetes Mellitus, Type 1 -- complications
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Angiopathies -- diagnosis
- Drug-Eluting Stents
- Everolimus
- Female
- Humans
- Kaplan-Meier Estimate
- Kidney Failure, Chronic -- complications
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Myocardial Infarction -- etiology
- Patient Selection
- Percutaneous Coronary Intervention -- adverse effects
- Propensity Score
- Proportional Hazards Models
- Prosthesis Design
- Registries
- Republic of Korea
- Risk Factors
- Sirolimus -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.